EPM2AIP1 and Insulin resistance: Moreover, the absence of EPM2AIP1 in mice impairs the allosteric activation of GS by glucose 6-phosphate, reduces liver glycogen synthesis, increases liver fat, and promotes liver insulin resistance [20].